Thomas Struengmann

About Thomas Struengmann

Birth Place: Tegernsee, Germany, Germany

Thomas Struengmann Net Worth

Thomas Struengmann was born in Tegernsee, Germany, Germany. In 2005, Thomas Struengmann and his twin brother, Andreas, who together founded generic drug maker Hexal AG in 1986, sold the business (along with their 68% stake in U.S.-based Eon Labs) to Novartis for $7.5 billion. Since then, they've been actively investing in biotechnology and pharmaceutical companies. Their holdings also include a private bank, Stuttgart-based Sudwestbank. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann. After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for the U.S. pharmaceutical company Schering-Plough. Like his brother, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches.
Thomas Struengmann is a member of Health care

💰 Net worth: $3.5 Billion (Updated at 22 June 2018)

2009 $3.6 Billion
2010 $3.8 Billion
2011 $3.9 Billion
2012 $3.3 Billion
2013 $3.4 Billion
2014 $3.5 Billion
2015 $3.3 Billion
2016 $3.2 Billion
2017 $3.1 Billion
2018 $3.72 Billion

Some Thomas Struengmann images